Left ventricular dysfunction as a risk factor for cardiovascular and noncardiovascular hospitalizations in African Americans

American Heart Journal

Volumn 160, Issue 3, 2010, Pages 488-495

  Blecker, Saul ^a,b   Matsushita, Kunihiro ^b   Fox, Ervin ^c   Russell, Stuart D ^a   Miller III, Edgar R ^a,b   Taylor, Herman ^c   Brancati, Frederick ^a,b   Coresh, Josef ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; ATTRIBUTABLE RISK; BINOMIAL DISTRIBUTION; CARDIOVASCULAR RISK; COMORBIDITY; DEMOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SYSTOLIC DYSFUNCTION; CONTROLLED STUDY; DIABETIC ANGIOPATHIES; ECHOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HYPERTENSION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AFRICAN AMERICANS; COMORBIDITY; DIABETIC ANGIOPATHIES; FEMALE; HOSPITALIZATION; HUMANS; HYPERTENSION; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MISSISSIPPI; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77956365454     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.06.035     Document Type: Article

References (40)

1. McMurray J.J., Petrie M.C., and Murdoch D.R. Clinical epidemiology of heart failure: public and private health burden Eur Heart J 19 Suppl P 1998 P9 P16
2. Liao L., Allen L.A., and Whellan D.J. Economic burden of heart failure in the elderly Pharmacoeconomics 26 2008 447 462
3. Lloyd-Jones D., Adams R., and Carnethon M. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 119 2009 e21 e181
4. Curtis L.H., Greiner M.A., and Hammill B.G. Early and long-term outcomes of heart failure in elderly persons, 2001-2005 Arch Intern Med 168 2008 2481 2488
5. Dunlay S.M., Redfield M.M., and Weston S.A. Hospitalizations after heart failure diagnosis a community perspective J Am Coll Cardiol 54 2009 1695 1702
6. Aranda Jr.J.M. Johnson J.W., and Conti J.B. Current trends in heart failure readmission rates: analysis of Medicare data Clin Cardiol 32 2009 47 52
7. Fang J., Mensah G.A., and Croft J.B. Heart failure-related hospitalization in the U.S., 1979 to 2004 J Am Coll Cardiol 52 2008 428 434
8. Alla F., Al-Hindi A.Y., and Lee C.R. Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fraction Am Heart J 153 2007 1074 1080
9. Babayan Z.V., McNamara R.L., and Nagajothi N. Predictors of cause-specific hospital readmission in patients with heart failure Clin Cardiol 26 2003 411 418
10. Fonarow G.C., Stough W.G., and Abraham W.T. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry J Am Coll Cardiol 50 2007 768 777
11. Smith G.L., Masoudi F.A., and Vaccarino V. Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline J Am Coll Cardiol 41 2003 1510 1518
12. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators N Engl J Med 327 1992 685 691
13. Pfeffer M.A., Braunwald E., and Moye L.A. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators N Engl J Med 327 1992 669 677
14. Bhatia R.S., Tu J.V., and Lee D.S. Outcome of heart failure with preserved ejection fraction in a population-based study N Engl J Med 355 2006 260 269
15. Lauer M.S., Evans J.C., and Levy D. Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham Heart Study) Am J Cardiol 70 1992 1180 1184
16. Raymond I., Mehlsen J., and Pedersen F. The prognosis of impaired left ventricular systolic function and heart failure in a middle-aged and elderly population in an urban population segment of Copenhagen Eur J Heart Fail 6 2004 653 661
17. Wang T.J., Evans J.C., and Benjamin E.J. Natural history of asymptomatic left ventricular systolic dysfunction in the community Circulation 108 2003 977 982
18. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators Am J Epidemiol. 129 1989 687 702
19. Collaborative Studies Coordinating Center, Department of Biostatistics, Gillings School of Public Health, University of North Carolina at Chapel Hill. Atherosclerosis Risk In Communities (ARIC) manuals Available at: http://www.cscc.unc.edu/aric/visit/index.php Last accessed March 25, 2010
20. Skelton T.N., Andrew M.E., and Arnett D.K. Echocardiographic left ventricular mass in African-Americans: the Jackson cohort of the Atherosclerosis Risk in Communities Study Echocardiography 20 2003 111 120
21. Quinones M.A., Waggoner A.D., and Reduto L.A. A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography Circulation 64 1981 744 753
22. Fox E.R., Taylor J., and Taylor H. Left ventricular geometric patterns in the Jackson cohort of the Atherosclerotic Risk in Communities (ARIC) Study: clinical correlates and influences on systolic and diastolic dysfunction Am Heart J 153 2007 238 244
23. Redfield M.M., Jacobsen S.J., and Burnett Jr.J.C.Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic JAMA 289 2003 194 202
24. Davies M., Hobbs F., and Davis R. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study Lancet 358 2001 439 444
25. Levey A.S., Coresh J., and Greene T. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate Ann Intern Med 145 2006 247 254
26. Eriksson H., Caidahl K., and Larsson B. Cardiac and pulmonary causes of dyspnoea-validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913 Eur Heart J 8 1987 1007 1014
27. Wilhelmsen L., Eriksson H., and Svardsudd K. Improving the detection and diagnosis of congestive heart failure Eur Heart J 10 Suppl C 1989 13 18
28. Kottgen A., Russell S.D., and Loehr L.R. Reduced kidney function as a risk factor for incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study J Am Soc Nephrol 18 2007 1307 1315
29. Anderson R.N., Minino A.M., and Hoyert D.L. Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates Natl Vital Stat Rep 49 2001 1 32
30. Greenland S., and Drescher K. Maximum likelihood estimation of the attributable fraction from logistic models Biometrics 49 1993 865 872
31. Le Jemtel T.H., Padeletti M., and Jelic S. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure J Am Coll Cardiol 49 2007 171 180
32. Jessup M., Abraham W.T., and Casey D.E. 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 1977 2016
33. Sarnak M.J., Levey A.S., and AC Schoolwerth Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Hypertension 42 2003 1050 1065
34. Krack A., Sharma R., and Figulla H.R. The importance of the gastrointestinal system in the pathogenesis of heart failure Eur Heart J 26 2005 2368 2374
35. Kober L., Torp-Pedersen C., and Carlsen J.E. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group N Engl J Med 333 1995 1670 1676
36. Vantrimpont P., Rouleau J.L., and Wun C.C. Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators J Am Coll Cardiol 29 1997 229 236
37. McMurray J.V., McDonagh T.A., and Davie A.P. Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure? Eur Heart J 19 1998 842 846
38. Galasko G.I., Barnes S.C., and Collinson P. What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination? Eur Heart J 27 2006 193 200
39. Wang T.J., Levy D., and Benjamin E.J. The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening Ann Intern Med 138 2003 907 916
40. Brown D.W., Haldeman G.A., and Croft J.B. Racial or ethnic differences in hospitalization for heart failure among elderly adults: Medicare, 1990 to 2000 Am Heart J 150 2005 448 454